世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000030283

OTC医薬品とサプリメント市場レポート2021-2031

Visiongain

OTC Drugs & Dietary Supplements Market Report 2021-2031

発刊日 2021/08/05

言語英語

体裁PDF/607ページ

ライセンス/価格607ページ

0000030283

Single - 1 Year License
(Departmental - 5 Users) - 1 Year License
Site
Global

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

流通経路別予測(薬局/ドラッグストア、スーパーマーケット/ハイパーマーケット、コンビニエンスストア、オンラインドラッグストア、健康食品店)、カテゴリ別(咳止め、風邪およびインフルエンザ薬、鎮痛薬、皮膚科薬、ビタミンおよびミネラル、減量/ダイエット製品、胃腸薬)、製品の種類別(先発医薬品、ジェネリック)、剤形別(錠剤、ハードカプセル、粉末、軟膏、ソフトカプセル、液剤)、地域および主要国別市場分析、主要OTCメーカーの分析、COVID-19回復シナリオ

OTC医薬品とサプリメント市場レポート2021-2031:
新たな収益源を求めて努力している大手企業が業界とその根底にあるダイナミクスをよりよく理解したいという場合、このレポートは非常に貴重であることが分かるでしょう。これはさまざまな業界に進出したり新しい地域で既存の事業を拡大したい企業に役立ちます。

グローバルヘルスシステムにおけるセルフケアが主要な公的資源になる
新興国や先進国の人々は今や自分たちの健康に対する意識が高く、フィットネスとウェルネスプログラムは世界中で拡大しています。免疫化と予防接種、子供の死亡率を減らし、子供の免疫力を高めるための予防措置、多くの健康的な食生活国での生活水準の向上、栄養補助食品(サプリメント)は、人々の平均余命を延ばすために世界的に採用されている重要な取り組みです。

サプリメントの質の高い啓もう活動の重要性
公衆衛生機関、執行機関、団体、業界、その他のグループは、質の高いサプリメントの選択に関するアドバイスを提供し、アイデンティティや品質に自信がない商品の潜在的なリスクを説明する教育プログラムに資金を提供すべきです。消費者は第三者からの独立した検証が製品や成分の表現を確立するのに役立つ可能性があることを認識しておく必要があります。感作キャンペーンは、消費者のセグメント(例えば高齢者、妊婦、軍人など)における低品質の食品の最も敏感なまたは予想される生理学的影響に的を絞ることが重要です。

レポート詳細

目次

1. Report Overview
1.1 Introduction to OTC Drugs & Dietary Supplements Market
1.2 Classification of OTC Pharmaceuticals
1.3 Global OTC Drugs & Dietary Supplements Market Overview
1.4 What are the Objectives of this Report?
1.5 What is the Scope of the Report?
1.6 OTC Drugs & Dietary Supplements Market Definition
1.6.1 Over The Counter (OTC) Drugs
1.6.2 Dietary Supplements
1.7 Why You Should Read This Report
1.8 What This Report Delivers
1.9 Key Questions Answered By This Analytical Report Include:
1.10 Who is This Report for?
1.11 Research Methodology
1.11.1 Primary Research
1.11.2 Secondary Research
1.11.3 Market Evaluation & Forecasting Methodology
1.12 Frequently Asked Questions (FAQs)
1.13 Associated Visiongain Reports
1.14 About Visiongain

2 Executive Summary

3 OTC Drugs & Dietary Supplements Industry Structure
3.1 Overview
3.2 Requirements for an OTC Pharmaceutical Drug
3.3 OTC Switching
3.3.1 A Prescription Medicine Switched To OTC
3.3.2 Manufacturing and Distribution of OTC Pharmaceuticals
3.4 COIVD Impact on OTC Product Sales
3.5 Regulation of OTC Pharmaceuticals
3.5.1 Regulation of OTC Pharmaceuticals in the US
3.5.2 Regulation of OTC Pharmaceuticals in Japan
3.5.3 Regulations of OTC Pharmaceuticals in Europe
3.5.4 Regulation of OTC Pharmaceuticals in Other Countries

4 Global Market Dynamics
4.1 Market Driving Factors
4.1.1 Self-Care In The Global Health System Becomes A Primary Public Resource
4.1.2 Importance Of Dietary Supplement Quality Education Campaigns
4.1.3 Leadership Retain Market
4.2 Market Restraining Factors
4.2.1 Pharmaceutical Companies Are Still Concentrating On Prescription Drugs.
4.2.2 OTC Drugs' Sales and Reputation are Affected by Manufacturing Issues
4.3 Opportunities in the Global Market
4.3.1 Growth Opportunities Will Emerge as a Result of Demographic and Economic Changes
4.3.2 Emerging Markets Are Booming.
4.3.3 OTC Approvals May Be Enabled By New Healthcare Technologies.
4.4 Challenges in the Global Market
4.4.1 Private Label Competition Will Reduce Profitability Competition
4.4.2 Product Withdrawal May Lead To Regulatory Concerns About Safety And Misuse
4.5 SWOT Analysis
4.6 PEST Analysis
4.6.1 Political
4.6.2 Economical
4.6.3 Social
4.6.4 Technology
4.7 Porters Five Forces
4.7.1 Competitor Rivalry [High]
4.7.2 New Entries Threat [Medium]
4.7.3 Suppliers' Power [Low]
4.7.4 Power of Buyers [Medium]
4.7.5 Threats of Substitutes (Medium)

5 Global OTC Drugs & Dietary Supplements Market Analysis
5.1 Global Market Outlook
5.1.1 OTC Market Overview
5.1.2 Dietary Supplement Market Overview
5.2 Pre-COVID-19 Market Scenario
5.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

6 Regional Market Size Estimation and Forecast
6.1 Pre-COVID-19 Market Scenario
6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

7 Market Size Estimation and Forecast By Distribution Channel
7.1 Segment Overview
7.1.1 Pharmacies/ Drugstores
7.1.2 Supermarkets/Hypermarkets
7.1.3 Convenience Stores
7.1.4 Online Drugstores
7.1.5 Health Food Stores
7.1.6 Other Distribution Channels
7.2 Pre-COVID-19 Market Scenario
7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

8 Global Market Size Estimation and Forecast By Category
8.1 Segment Overview
8.1.1 Cough, Cold and Flu Drugs
8.1.2 Cough And Cold Remedies
8.1.3 Dermatological
8.1.4 Vitamins and Minerals
8.1.5 Weight Loss/Diet Products
8.1.6 Gastrointestinal Drugs
8.1.7 Allergy
8.1.8 Other Categories
8.2 Pre-COVID-19 Market Scenario
8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

9 Global Market Size Estimation and Forecast by Allergy Type
9.1 Segment Overview
9.1.1 Eye Allergy
9.1.2 Rhinitis
9.1.3 Asthma
9.1.4 Skin Allergy
9.1.5 Food Allergies
9.1.6 Other Allergies
9.2 Pre-COVID-19 Market Scenario
9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

10 Global Market Size Estimation and Forecast by Allergy Drugs
10.1 Segment Overview
10.1.1 Antihistamines
10.1.2 Corticosteroids
10.1.3 Decongestants
10.1.4 Other Allergy Drugs
10.2 Pre-COVID-19 Market Scenario
10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

11 Global Market Size Estimation and Forecast by Product Type
11.1 Segment Overview
11.1.1 Branded Drugs
11.1.2 Generic Drugs
11.2 Pre-COVID-19 Market Scenario
11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

12 Global Market Size Estimation and Forecast by Dosage Form
12.1 Segment Overview
12.1.1 Tablets
12.1.2 Hard Capsules
12.1.3 Powders
12.1.4 Ointments
12.1.5 Soft Capsule
12.1.6 Liquid Dosage
12.1.7 Other Dosage
12.2 Pre-COVID-19 Market Scenario
12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

13 North America OTC Drugs & Dietary Supplements Market Analysis
13.1 North America Market Size Estimation and Forecast
13.1.1 Pre-COVID-19 Market Scenario
13.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.2 Country Market Size Estimation and Forecast
13.3 US Market Analysis
13.3.1 OTC Pharmaceuticals in US
13.3.2 Dietary Supplements in US
13.4 Canada Market Analysis
13.4.1 OTC Pharmaceuticals in Canada
13.4.2 Dietary Supplements in Canada
13.4.3 Pre-COVID-19 Market Scenario
13.4.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Market Size Estimation and Forecast By Distribution Channel
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 North America Market Size Estimation and Forecast Category
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 North America Market Size Estimation and Forecast by Allergy Type
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 North America Market Size Estimation and Forecast by Allergy Drugs
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 North America Market Size Estimation and Forecast by Product Type
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 North America Market Size Estimation and Forecast by Dosage Form
13.10.1 Pre-COVID-19 Market Scenario
13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 North America Market Size Estimation and Forecast by Allergy Type
13.11.1 Pre-COVID-19 Market Scenario
13.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 North America Market Size Estimation and Forecast by Allergy Drugs
13.12.1 Pre-COVID-19 Market Scenario
13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

14 Europe OTC Drugs & Dietary Supplements Market Analysis
14.1 Europe Market Outlook
14.2 Europe Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Regional Market Size Estimation and Forecast
14.3.1 UK Market Analysis
14.3.2 Germany Market Analysis
14.3.3 France Market Analysis
14.3.4 Italy Market Analysis
14.3.5 Spain Market Analysis
14.3.6 Russia Market Analysis
14.3.7 Belgium Market Analysis
14.3.8 Netherland Market Analysis
14.3.9 Switzerland Market Analysis
14.3.10 Rest of Europe Market Analysis
14.3.11 Pre-COVID-19 Market Scenario
14.3.12 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Market Size Estimation and Forecast By Distribution Channel
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Europe Market Size Estimation and Forecast Category
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Europe Market Size Estimation and Forecast by Allergy Type
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Europe Market Size Estimation and Forecast by Allergy Drugs
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Europe Market Size Estimation and Forecast by Product Type
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Europe Market Size Estimation and Forecast by Dosage Form
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

15 Asia-Pacific OTC Drugs & Dietary Supplements Market Analysis
15.1 Asia-Pacific Market Outlook
15.2 Asia-Pacific Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Regional Market Size Estimation and Forecast
15.3.1 China Market Analysis
15.3.2 India Market Analysis
15.3.3 Japan Market Analysis
15.3.4 South Korea Market Analysis
15.3.5 Australia Market Analysis
15.3.6 Singapore Market Analysis
15.3.7 Malaysia Market Analysis
15.3.8 Indonesia Market Analysis
15.3.9 Philippines Market Analysis
15.3.10 Rest of Asia-Pacific Market Analysis
15.3.11 Pre-COVID-19 Market Scenario
15.3.12 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 Market Size Estimation and Forecast by Distribution Channel
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 Asia-Pacific Market Size Estimation and Forecast Category
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 Asia-Pacific Market Size Estimation and Forecast by Allergy Type
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 Asia-Pacific Market Size Estimation and Forecast by Allergy Drugs
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 Asia-Pacific Market Size Estimation and Forecast by Product Type
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 Asia-Pacific Market Size Estimation and Forecast by Dosage Form
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

16 Latin America OTC Drugs & Dietary Supplements Market Analysis
16.1 Latin America Market Outlook
16.2 Latin America Market Size Estimation and Forecast
16.2.1 Pre-COVID-19 Market Scenario
16.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.3 Regional Market Size Estimation and Forecast
16.3.1 Brazil Market Analysis
16.3.2 Mexico Market Analysis
16.3.3 Colombia Market Analysis
16.3.4 Argentina Market Analysis
16.3.5 Rest of Latin America Market Analysis
16.3.6 Pre-COVID-19 Market Scenario
16.3.7 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.4 Market Size Estimation and Forecast by Distribution Channel
16.4.1 Pre-COVID-19 Market Scenario
16.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.5 Latin America Market Size Estimation and Forecast Category
16.5.1 Pre-COVID-19 Market Scenario
16.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.6 Latin America Market Size Estimation and Forecast by Allergy Type
16.6.1 Pre-COVID-19 Market Scenario
16.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.7 Latin America Market Size Estimation and Forecast by Allergy Drugs
16.7.1 Pre-COVID-19 Market Scenario
16.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.8 Latin America Market Size Estimation and Forecast by Product Type
16.8.1 Pre-COVID-19 Market Scenario
16.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.9 Latin America Market Size Estimation and Forecast by Dosage Form
16.9.1 Pre-COVID-19 Market Scenario
16.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

17 Middle East & Africa OTC Drugs & Dietary Supplements Market Analysis
17.1 Middle East & Africa Market Outlook
17.2 Middle East & Africa Market Size Estimation and Forecast
17.2.1 Pre-COVID-19 Market Scenario
17.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
17.3 Regional Market Size Estimation and Forecast
17.3.1 South Africa Market Analysis
17.3.2 OTC Drugs in South Africa
17.3.3 Dietary Supplements in South Africa
17.3.4 Turkey Market Analysis
17.3.5 Dietary Supplements in Turkey
17.3.6 UAE Market Analysis
17.3.7 OTC Drugs in UAE
17.3.8 Dietary Supplement in UAE
17.3.9 Qatar Market Analysis
17.3.10 Rest of Middle East & Africa Market Analysis
17.3.11 Pre-COVID-19 Market Scenario
17.3.12 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
17.4 Middle East & Africa Market Size Estimation and Forecast by Distribution Channel
17.4.1 Pre-COVID-19 Market Scenario
17.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
17.5 Middle East & Africa Market Size Estimation and Forecast Category
17.5.1 Pre-COVID-19 Market Scenario
17.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
17.6 Middle East & Africa Market Size Estimation and Forecast by Allergy Type
17.6.1 Pre-COVID-19 Market Scenario
17.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
17.7 Middle East & Africa Market Size Estimation and Forecast by Allergy Drugs
17.7.1 Pre-COVID-19 Market Scenario
17.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
17.8 Middle East & Africa Market Size Estimation and Forecast by Product Type
17.8.1 Pre-COVID-19 Market Scenario
17.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
17.9 Middle East & Africa Market Size Estimation and Forecast by Dosage Form
17.9.1 Pre-COVID-19 Market Scenario
17.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

18 Companies Profiles
18.1 Taisho Pharmaceutical Holdings Co., Ltd
18.1.1 Company Snapshot
18.1.2 Company Overview
18.1.3 Company Financial Profile
18.1.4 Company Product Benchmarking
18.1.5 Company Recent Developments
18.2 Nippon Chemiphar Co., Ltd.
18.2.1 Company Snapshot
18.2.2 Company Overview
18.2.3 Company Financial Profile
18.2.4 Company Product Benchmarking
18.2.5 Company Recent Developments
18.3 H Lundbeck A/S
18.3.1 Company Snapshot
18.3.2 Company Overview
18.3.3 Company Financial Profile
18.3.4 Company Product Benchmarking
18.3.5 Company Recent Developments
18.4 Teva Pharmaceutical Industries Ltd
18.4.1 Company Snapshot
18.4.2 Company Overview
18.4.3 Company Financial Profile
18.4.4 Company Product Benchmarking
18.4.5 Company Recent Developments
18.5 Novartis AG
18.5.1 Company Snapshot
18.5.2 Company Overview
18.5.3 Company Financial Profile
18.5.4 Company Product Benchmarking
18.5.5 Company Recent Developments
18.6 Pfizer Inc.
18.6.1 Company Snapshot
18.6.2 Company Overview
18.6.3 Company Financial Profile
18.6.4 Company Product Benchmarking
18.6.5 Company Recent Developments
18.7 Mylan N.V.
18.7.1 Company Snapshot
18.7.2 Company Overview
18.7.3 Company Financial Profile
18.7.4 Company Product Benchmarking
18.7.5 Company Recent Developments
18.8 Abbott Laboratories
18.8.1 Company Snapshot
18.8.2 Company Overview
18.8.3 Company Financial Profile
18.8.4 Company Product Benchmarking
18.8.5 Company Recent Developments
18.9 Fresenius SE & Co KgaA
18.9.1 Company Snapshot
18.9.2 Company Overview
18.9.3 Company Financial Profile
18.9.4 Company Product Benchmarking
18.9.5 Company Recent Developments
18.10 Sun Pharmaceutical Industries
18.10.1 Company Snapshot
18.10.2 Company Overview
18.10.3 Company Financial Profile
18.10.4 Company Product Benchmarking
18.10.5 Company Recent Developments
18.11 Sanofi SA
18.11.1 Company Snapshot
18.11.2 Company Overview
18.11.3 Company Financial Profile
18.11.4 Company Product Benchmarking
18.11.5 Company Recent Developments
18.12 Roche Holding AG
18.12.1 Company Snapshot
18.12.2 Company Overview
18.12.3 Company Financial Profile
18.12.4 Company Product Benchmarking
18.12.5 Company Recent Developments
18.13 Lupin
18.13.1 Company Snapshot
18.13.2 Company Overview
18.13.3 Company Financial Profile
18.13.4 Company Product Benchmarking
18.13.5 Company Recent Developments
18.14 Alcon AG
18.14.1 Company Snapshot
18.14.2 Company Overview
18.14.3 Company Financial Profile
18.14.4 Company Product Benchmarking
18.14.5 Company Recent Developments
18.15 Sato Pharmaceutical
18.15.1 Company Snapshot
18.15.2 Company Overview
18.15.3 Company Product Benchmarking
18.16 Herbalife Nutrition Ltd
18.16.1 Company Snapshot
18.16.2 Company Overview
18.16.3 Company Financial Profile
18.16.4 Company Product Benchmarking
18.17 Bayer AG.
18.17.1 Company Snapshot
18.17.2 Company Overview
18.17.3 Company Financial Profile
18.17.4 Company Product Benchmarking
18.17.5 Company Recent Developments
18.18 Glanbia plc
18.18.1 Company Snapshot
18.18.2 Company Overview
18.18.3 Company Financial Profile
18.18.4 Company Product Benchmarking
18.19 Nature’s Sunshine Products, Inc. (NSP)
18.19.1 Company Snapshot
18.19.2 Company Overview
18.19.3 Company Financial Profile
18.19.4 Company Product Benchmarking
18.20 Danisco
18.20.1 Company Snapshot
18.20.2 Company Overview
18.20.3 Company Product Benchmarking

19 Conclusion and Recommendations
19.1 Concluding Remarks from Visiongain
19.2 Recommendations for Market Players
19.2.1 Rx-to-OTC Switch is The Upcoming Trends
19.2.2 Cost Of OTC Drugs is Less as Compared to Prescribed Drugs
19.2.3 Strict Regulatory Framework

List of Tables
Table 1. Global OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 2. Global OTC Drugs & Dietary Supplements Market Snapshot, 2021 & 2031 (US$billion, CAGR %)
Table 3. Global OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 4. Global OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 5. Global OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 6. Global OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 7. Global OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 8. Global OTC Drugs & Dietary Supplements Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 9. Global OTC Drugs & Dietary Supplements Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 10. Global OTC Drugs & Dietary Supplements Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 11. Global OTC Drugs & Dietary Supplements Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 12. Global OTC Drugs & Dietary Supplements Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 13. Global OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 14. Global OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 15. Global OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 16. Global OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 17. Global OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 18. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 19. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 20. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 21. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 22. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 23. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 24. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 25. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 26. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 27. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 28. Global OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 29. Global OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 30. Global OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 31. Global OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 32. Global OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 33. Global OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 34. Global OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 35. Global OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 36. Global OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 37. Global OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 38. Global OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 39. Global OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 40. Global OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 41. Global OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 42. Global OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 43. North America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 44. North America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 45. North America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 46. North America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 47. North America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 48. North America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 49. North America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 50. North America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 51. North America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 52. North America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 53. North America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 54. North America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 55. North America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 56. North America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 57. North America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 58. North America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 59. North America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 60. North America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 61. North America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 62. North America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 63. North America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 64. North America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 65. North America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 66. North America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 67. North America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 68. North America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 69. North America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 70. North America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 71. North America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 72. North America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 73. North America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 74. North America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 75. North America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 76. North America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 77. North America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 78. North America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 79. North America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 80. North America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 81. North America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 82. North America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 83. Europe OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 84. Europe OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 85. Europe OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 86. Europe OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 87. Europe OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 88. Europe OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 89. Europe OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 90. Europe OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 91. Europe OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 92. Europe OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 93. Europe OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 94. Europe OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 95. Europe OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 96. Europe OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 97. Europe OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 98. Europe OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 99. Europe OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 100. Europe OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 101. Europe OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 102. Europe OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 103. Europe OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 104. Europe OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 105. Europe OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 106. Europe OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 107. Europe OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 108. Europe OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 109. Europe OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 110. Europe OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 111. Europe OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 112. Europe OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 113. Europe OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 114. Europe OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 115. Europe OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 116. Europe OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 117. Europe OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 118. Europe OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 119. Europe OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 120. Europe OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 121. Europe OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 122. Europe OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 123. Asia-Pacific OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 124. Asia-Pacific OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 125. Asia-Pacific OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 126. Asia-Pacific OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 127. Asia-Pacific OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 128. Asia-Pacific OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 129. Asia-Pacific OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 130. Asia-Pacific OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 131. Asia-Pacific OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 132. Asia-Pacific OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 133. Asia-Pacific OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 134. Asia-Pacific OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 135. Asia-Pacific OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 136. Asia-Pacific OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 137. Asia-Pacific OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 138. Asia-Pacific OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 139. Asia-Pacific OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 140. Asia-Pacific OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 141. Asia-Pacific OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 142. Asia-Pacific OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 143. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 144. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 145. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 146. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 147. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 148. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 149. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 150. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 151. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 152. Asia-Pacific OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 153. Asia-Pacific OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 154. Asia-Pacific OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 155. Asia-Pacific OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 156. Asia-Pacific OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 157. Asia-Pacific OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 158. Asia-Pacific OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 159. Asia-Pacific OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 160. Asia-Pacific OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 161. Asia-Pacific OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 162. Asia-Pacific OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 163. Latin America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 164. Latin America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 165. Latin America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 166. Latin America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 167. Latin America OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 168. Latin America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 169. Latin America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 170. Latin America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 171. Latin America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 172. Latin America OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 173. Latin America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 174. Latin America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 175. Latin America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 176. Latin America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 177. Latin America OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 178. Latin America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 179. Latin America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 180. Latin America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 181. Latin America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 182. Latin America OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 183. Latin America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 184. Latin America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 185. Latin America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 186. Latin America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 187. Latin America OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 188. Latin America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 189. Latin America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 190. Latin America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 191. Latin America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 192. Latin America OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 193. Latin America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 194. Latin America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 195. Latin America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 196. Latin America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 197. Latin America OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 198. Latin America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 199. Latin America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 200. Latin America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 201. Latin America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 202. Latin America OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 203. Middle East & Africa OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 204. Middle East & Africa OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 205. Middle East & Africa OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 206. Middle East & Africa OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 207. Middle East & Africa OTC Drugs & Dietary Supplements Market, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 208. Middle East & Africa OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 209. Middle East & Africa OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 210. Middle East & Africa OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 211. Middle East & Africa OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 212. Middle East & Africa OTC Drugs & Dietary Supplements Market by Country, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 213. Middle East & Africa OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 214. Middle East & Africa OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 215. Middle East & Africa OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 216. Middle East & Africa OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 217. Middle East & Africa OTC Drugs & Dietary Supplements Market by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 218. Middle East & Africa OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 219. Middle East & Africa OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 220. Middle East & Africa OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 221. Middle East & Africa OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 222. Middle East & Africa OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 223. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 224. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 225. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 226. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 227. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 228. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 229. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 230. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 231. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 232. Middle East & Africa OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 233. Middle East & Africa OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 234. Middle East & Africa OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 235. Middle East & Africa OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 236. Middle East & Africa OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 237. Middle East & Africa OTC Drugs & Dietary Supplements Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 238. Middle East & Africa OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 239. Middle East & Africa OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 240. Middle East & Africa OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 241. Middle East & Africa OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 242. Middle East & Africa OTC Drugs & Dietary Supplements Market by Dosage Form, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L - Shaped Recovery)
Table 243. Taisho Pharmaceutical Holdings Co., Ltd.: Company Information
Table 244. Taisho Pharmaceutical Holdings Co., Ltd.: Company Service Benchmarking
Table 245. Taisho Pharmaceutical Holdings Co., Ltd.: Company Recent Development Till Apr,2021
Table 246. Nippon Chemiphar Co., Ltd..: Company Information
Table 247. Nippon Chemiphar Co., Ltd..: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 248. Nippon Chemiphar Co., Ltd..: Company Service Benchmarking
Table 249. Nippon Chemiphar Co. Ltd..: Company Recent Development Till Apr,2021
Table 250. H Lundbeck A/S: Company Information
Table 251. H Lundbeck A/S: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 252. H Lundbeck A/S: Company Product and Service Benchmarking
Table 253. H Lundbeck A/S.: Company Recent Development Till Apr,2021
Table 254. Teva Pharmaceutical Industries Ltd : Company Information
Table 255. Teva Pharmaceutical Industries Ltd : Company Revenue 2016-2020(US$Mn, AGR %)
Table 256. Teva Pharmaceutical Industries Ltd .: Company Recent Developments till Feb,2021
Table 257. Novartis AG: Company Information
Table 258. Novartis AG: Company Revenue 2016-2020(US$Mn, AGR %)
Table 259. Novartis AG : Company Product and Service Benchmarking
Table 260. Novartis AG .: Company Recent Developments till Feb,2021
Table 261. Pfizer Inc.: Company Information
Table 262. Pfizer Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 263. Pfizer Inc.: Company Product and Service Benchmarking
Table 264. Pfizer Inc .: Company Recent Developments till Feb,2021
Table 265. Mylan N.V..: Company Information
Table 266. Mylan N.V.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 267. Mylan N.V .: Company Recent Developments till Feb,2021
Table 268. Abbott Laboratories.: Company Information
Table 269. Abbott Laboratories.: Company Revenue 2016-2020(US$Mn, AGR %)
Table 270. Abbott Laboratories .: Company Product and Service Benchmarking
Table 271. Abbott Laboratories.: Company Recent Developments till Feb,2021
Table 272. Fresenius SE & Co KgaA.: Company Information
Table 273. Fresenius SE & Co KgaA.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 274. Fresenius SE & Co KgaA.: Company Product and Service Benchmarking
Table 275. Fresenius SE & Co KgaA.: Company Recent Developments till Feb,2021
Table 276. Sun Pharmaceutical Industries.: Company Information
Table 277. Sun Pharmaceutical Industries.: Company Revenue 2016-2020(US$Mn, AGR %)
Table 278. Sun Pharmaceutical Industries.: Company Product and Service Benchmarking
Table 279. Sun Pharmaceutical Industries.: Company Recent Developments till Feb,2021
Table 280. Sanofi SA.: Company Information
Table 281. Sanofi SA.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 282. Sanofi SA.: Company Product and Service
Table 283. Sanofi SA.: Company Recent Developments till Feb,2021
Table 284. Roche Holding AG.: Company Information
Table 285. Roche Holding AG: Revenue 2016-2020 (US$Mn, AGR %)
Table 286. Roche Holding AG: Product and Service
Table 287. Roche Holding AG.: Company Recent Developments till Feb,2021
Table 288. Lupin Limited: Company Information
Table 289. Lupin Limited: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 290. Lupin Limited: Product and Service
Table 291. Lupin Limited.: Company Recent Developments till Feb,2021
Table 292. Alcon AG : Company Information
Table 293. Alcon AG.: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 294. Lupin Limited: Product and Service
Table 295. Alcon AG.: Company Recent Developments till Feb,2021
Table 296. Sato Pharmaceutical.: Company Information
Table 297. Sato Pharmaceutical .: Company Product and Service Benchmarking
Table 298. Herbalife Nutrition Ltd.: Company Information
Table 299. Herbalife Nutrition Ltd.: Company Service Benchmarking
Table 300. Bayer AG..: Company Information
Table 301. Bayer AG..: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 302. Bayer AG..: Company Service Benchmarking
Table 303. Bayer AG..: Company Recent Developments till Apr,2021
Table 304. Glanbia plc: Company Information
Table 305. Glanbia plc: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 306. Glanbia plc: Company Product and Service Benchmarking
Table 307. Nature’s Sunshine Products, Inc. (NSP) : Company Information
Table 308. Nature’s Sunshine Products, Inc. (NSP) : Company Revenue 2016-2020(US$Mn, AGR %)
Table 309. Danisco: Company Information
Table 310. Bayer AG..: Company Service Benchmarking
Table 311. Glossary Terms

List of Figures
Figure 1. Global OTC Drugs & Dietary Supplements Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR (%))
Figure 2. Global OTC Drugs & Dietary Supplements Market Segmentation
Figure 3. Global OTC Drugs & Dietary Supplements Market Segmentation
Figure 4. OTC Pharmaceutical Supply Chain
Figure 5. Global OTC Drugs & Dietary Supplements Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR (%))
Figure 6. Global OTC Drugs & Dietary Supplements Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR (%))
Figure 7. Global OTC Drugs & Dietary Supplements Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR (%))
Figure 8. Global OTC Drugs & Dietary Supplements Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 9. Global OTC Drugs & Dietary Supplements Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 10. Global OTC Drugs & Dietary Supplements Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 11. Global OTC Drugs & Dietary Supplements Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 12. Global OTC Drugs & Dietary Supplements Market Forecast by Region, 2021-2031 (USD Bn, AGR (%), CAGR (%))
Figure 13. Global OTC Drugs & Dietary Supplements Market Forecast by Region, 2021-2031 (USD Bn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 14. Global OTC Drugs & Dietary Supplements Market Forecast by Region, 2021-2031 (USD Bn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 15. Global OTC Drugs & Dietary Supplements Market Forecast by Region, 2021-2031 (USD Bn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 16. Global OTC Drugs & Dietary Supplements Market Forecast by Region, 2021-2031 (USD Bn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 17. Global OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR (%))
Figure 18. Global OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Figure 19. Global OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Figure 20. Global OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Figure 21. Global OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2021-2031 (USD Bn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Figure 22. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%))
Figure 23. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery)
Figure 24. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery)
Figure 25. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery)
Figure 26. Global OTC Drugs & Dietary Supplements Market by Category, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery)
Figure 27. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%))
Figure 28. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery)
Figure 29. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery)
Figure 30. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery)
Figure 31. Global OTC Drugs & Dietary Supplements Market by Allergy Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery)
Figure 32. Global OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%))
Figure 33. Global OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery)
Figure 34. Global OTC Drugs & Dietary Supplements Market by Allergy Drugs, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery)
Figure

この商品のレポートナンバー

0000030283

TOP